Pages that link to "Q36961731"
Jump to navigation
Jump to search
The following pages link to A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease (Q36961731):
Displaying 50 items.
- Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease (Q26781122) (← links)
- Prevalence, etiology, and treatment of depression in Parkinson's disease (Q28191314) (← links)
- Clinical characteristics with an impact on ADL functions of PD patients with cognitive impairment indicative of dementia (Q30445877) (← links)
- Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease (Q30476582) (← links)
- Biological risk factors in late life depression (Q30714232) (← links)
- Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease (Q33647691) (← links)
- The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease. (Q33857755) (← links)
- Clinical correlates of depressive symptoms in familial Parkinson's disease (Q33861294) (← links)
- Postural control in bipolar disorder: increased sway area and decreased dynamical complexity. (Q33911062) (← links)
- Parkinson's disease: the quintessential neuropsychiatric disorder (Q33917094) (← links)
- The spectrum of cognitive impairment in Lewy body diseases (Q34019751) (← links)
- SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. (Q34067137) (← links)
- Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease (Q34089583) (← links)
- Neurobehavioral aspects of movement disorders (Q34353518) (← links)
- Depression and Parkinson's disease: current knowledge (Q34382560) (← links)
- Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic Management (Q34442089) (← links)
- Neuropsychiatry of the basal ganglia (Q34489109) (← links)
- Management of Parkinson's disease. Strategies, pitfalls, and future directions (Q34490418) (← links)
- Psychiatric aspects of Parkinson's disease (Q34574771) (← links)
- Neurophysiological correlate of clinical signs in Parkinson's disease (Q34669765) (← links)
- Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease (Q34733143) (← links)
- The relation of hypertension to changes in ADL/IADL limitations of Mexican american older adults. (Q35021160) (← links)
- Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease (Q35040826) (← links)
- The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up. (Q35098556) (← links)
- Neuropsychiatric aspects of Parkinson's disease: recent advances (Q35103472) (← links)
- Neuropsychology for Movement Disorders Neurosurgery (Q35105765) (← links)
- A chronic generalized bi-directional brain-machine interface (Q35135668) (← links)
- Dementia associated with Parkinson's disease (Q35172297) (← links)
- Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial (Q35269306) (← links)
- Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy (Q35459280) (← links)
- What causes mental dysfunction in Parkinson's disease? (Q35540203) (← links)
- The impact of mood disorders in neurological diseases: should neurologists be concerned? (Q35573292) (← links)
- Mood and motor trajectories in Parkinson's disease: multivariate latent growth curve modeling (Q35812942) (← links)
- Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilization (Q36024004) (← links)
- Effect of age on geriatric depression scale performance in Parkinson's disease (Q36025220) (← links)
- Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample (Q36026290) (← links)
- Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease (Q36037251) (← links)
- The impact of depressive symptoms in early Parkinson disease (Q36074454) (← links)
- Should neurologists be trained to recognize and treat comorbid depression of neurologic disorders? Yes. (Q36093563) (← links)
- Alpha-synuclein and familial Parkinson's disease (Q36095686) (← links)
- Transcranial magnetic stimulation for the treatment of depression in neurologic disorders (Q36282276) (← links)
- A matter of motion or an emotional matter? Management of depression in Parkinson's disease (Q36307871) (← links)
- Neuropsychiatric features of corticobasal degeneration. (Q36318961) (← links)
- Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis (Q36419572) (← links)
- Prevalence of depression in Parkinson's disease patients in Ethiopia (Q36457496) (← links)
- Non-motor aspects of Parkinson's disease. (Q36525764) (← links)
- Telephone-based cognitive-behavioral therapy for depression in Parkinson disease (Q36607616) (← links)
- Conceptualization of depression in Parkinson's disease (Q36700296) (← links)
- Depressive symptoms in Parkinson's disease and in non-neurological medical illnesses. (Q36738506) (← links)
- Barriers to mental health care utilization in Parkinson's disease (Q36816273) (← links)